# Validation Report: biomarker-knowledge-base.yaml

**Document under validation**: `wiki/biomarker-knowledge-base.yaml`

**Methodology**: per `VALIDATION.md` — 5 categories (Accuracy, Relevance, Clarity, Completeness, Falsity) × 4 prompting styles (Contextual, Non-contextual, Argumentative, Querying) = 20 cells per response. Each cell scored 1–3; sum of the 4 cells per category (max 12) — ≥8 = PASS, <8 = FAIL. Every cell derived independently/blindly, with no backward-referencing between cells, categories, or responses. The user makes the final overall PASS/FAIL judgment; this report computes per-category verdicts only.

**Date**: 2026-08-04

---

## Response split

Two responses were defined, each validated against only the source PDFs relevant to its own content:

- **Response A**: lines 107–243 — the `sources:` registry block (9 source entries: bibliographic and methodological metadata for each cited paper).
- **Response B**: lines 646–771 — the tail of the β-hCG biomarker entry (`findings` list + `assay_note`), plus the full PAPP-A and PlGF biomarker entries.

Per user instruction, `wiki_page` field values were treated as filename strings only — not opened or verified as comparison material. The `authors:` registry block (lines 41–99) was used as necessary lookup context to resolve author_id references within Response A, but its own text (the descriptive parenthetical author annotations) is outside Response A's evaluated scope.

## Comparison material — Response A

9 source PDFs in `raw/`, one per registry entry:

| source_id | file |
|---|---|
| src_ijms25_09722 | ijms-25-09722.pdf |
| src_ijms26_06187 | ijms-26-06187.pdf |
| src_chen_2020 | 1-s2.0-S014340042030374X-main.pdf |
| src_zhang_2022_ratio | 1-s2.0-S0143400422002478-main.pdf |
| src_sundet_2025 | 1-s2.0-S0143400425006903-main.pdf |
| src_shang_2025 | 10.1515_jpm-2025-0291.pdf |
| src_lu_2025_ddvdr | 12880_2025_Article_1735.pdf |
| src_lu_2022_dwi | 12884_2022_Article_4644.pdf |
| src_jiang_qu_2024_cvf | 12884_2024_Article_7065.pdf |

Of these, 4 were read directly in full (src_ijms25_09722, src_ijms26_06187, src_chen_2020, src_jiang_qu_2024_cvf); the remaining 5 were fact-extracted by a background research agent and cross-checked structurally (DOI-suffix vs. filename matching, source_id/year self-consistency) rather than read directly by the validator.

---

# Response A

**Text under evaluation**: `wiki/biomarker-knowledge-base.yaml`, lines 107–243 (the full `sources:` registry — 9 entries).

## Accuracy

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a terminology-substitution audit to cite instances of incorrect rephrasing and misleading language in the response. | src_ijms26_06187's `study_type: case_control` drops "retrospective" though the source states "retrospective case–control study" twice, and a sibling entry (src_shang_2025) preserves the fuller qualifier. src_jiang_qu_2024_cvf's title silently corrects the source's own "accrete" typo to "accreta." Its `study_type: pilot_cross_sectional` uses different design vocabulary than structurally similar entries elsewhere labeled `case_control`. Its `placenta-previa` tag mildly overstates scope (PP is a baseline characteristic, not an independent comparison arm). | 2 |
| Non-contextual | Discover the accuracy of the response. | A claim-by-claim numeric ledger (DOI/year/journal) found 0 misconceptions across the 3 directly-verified entries, and no internal contradictions (DOI-vs-filename, source_id-vs-year) across the other 6 — though this internal check can't catch an error consistently wrong across all fields. | 3 |
| Argumentative | Argue defensively or accusatorily whether the response is accurate using a terminology-substitution audit. | Defense: titles, journals, DOIs all verified exact across 4 directly-checked entries; the cohort_overlap_flag and in_scope:false flag are both rigorously, independently corroborated; author truncation is always disclosed. Accusation: src_shang_2025 self-contradicts (`study_type: retrospective_case_control` vs. tag `retrospective-cohort`); src_shang_2025's year (2025) reflects online-first date, not the 2026 print-issue citation; a systematic pattern across 3 entries truncates author lists to first-listed authors while omitting the actual corresponding author; src_lu_2025_ddvdr's "retrospective" label has no confirmed source-text anchor. | 2 |
| Querying | If a terminology-substitution audit was conducted, what would it reveal about the response's accuracy? | A tags-only sweep found src_jiang_qu_2024_cvf's `proteomics` tag omits `metabolomics` despite the source's confirmed, co-equal dual-omics design (127 differential proteins, 12 differential metabolites) — a real narrowing of demonstrated scope. The `placenta-previa` tag on the same entry is more defensible than first assumed: Table 1 shows a statistically significant (p<0.05) baseline difference in previa prevalence between groups. | 2 |

**Sum = 2+3+2+2 = 9 → PASS**

## Relevance

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a counterfactual removal test to cite instances of scope oscillation through suggestively irrelevant details in the response not found in the source. | Field-by-field removal testing found almost nothing removable as suggestive padding — the cohort_overlap_flag and in_scope:false note are both verified, load-bearing content, not filler. The only counterfactually-removable fields are `pmid: null` and `ingested: true`, which are constant across all 9 entries and non-differentiating, but read as inert schema artifacts rather than misleading content. | 3 |
| Non-contextual | Discover the relevance of the response. | Scope-membership classification: 8 of 9 entries are unambiguous topical matches for a PAS/previa biomarker registry. src_sundet_2025 genuinely doesn't fit (studies preeclampsia/SGA/fetal sex, no PAS/previa mention) but is transparently flagged `in_scope: false` with an accurate explanatory note, so no reader is misled. | 3 |
| Argumentative | Argue defensively or accusatorily whether the response is relevant using a counterfactual removal test. | Defense: entry-level removal testing shows 8 of 9 entries are demonstrably load-bearing, each contributing a unique study design, biomarker signal, or (for the two Lu MRI papers) a mutually-necessary half of a corroborated cohort-overlap pair. Accusation: src_sundet_2025 does not survive entry-level removal testing — it contributes no downstream biomarker findings I could identify, so it is one whole entry (11% of Response A) that could be deleted with no functional loss, despite being honestly disclosed. | 2 |
| Querying | If a counterfactual removal test were conducted, what would it reveal about the relevance of the response? | A tag-level sweep (40 individual tags across 9 entries) found no genuinely redundant tag — every tag serves a distinct, non-duplicated filtering function. Notably, src_sundet_2025 carries neither `PAS` nor `placenta-previa`, consistent with its disclosed out-of-scope status rather than inflating its apparent relevance. | 3 |

**Sum = 3+3+2+3 = 11 → PASS**

## Clarity

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a reader-path branch-point simulation and paraphrase test to cite instances of un-conciseness and ambiguity in the response. | The cohort_overlap_flag's "overlapping/nested" phrasing conflates two non-synonymous relationship types (partial intersection vs. full containment) without indicating which applies. `pmid: null` (present identically on all 9 entries) can't distinguish "confirmed absent" from "not yet looked up." `authors_truncated: true` paired with a single-element author_ids list (src_chen_2020) risks a first-pass misreading as "this name is abbreviated" rather than "this list omits co-authors." | 2 |
| Non-contextual | Discover the clarity of the response. | A structural inventory found consistent field ordering and formatting across all 9 entries, but a systematic casing-convention split: `study_type` values use snake_case while `tags` use kebab-case for the same underlying concepts — most visible where src_shang_2025's two fields use genuinely different design-category terms. Doesn't obstruct comprehension, but is a real file-wide inconsistency. | 3 |
| Argumentative | Argue defensively or accusatorily whether the response is clear using a reader-path branch-point simulation and paraphrase test. | Defense: most fields (title, authors, year, journal, DOI, PMID) carry universally understood meanings; `ingested` vs. `wiki_page` resolve cleanly on inspection as a status flag vs. a reference pointer. Accusation: `study_type: pilot_cross_sectional` on src_jiang_qu_2024_cvf reads as extracted-from-source, but the word "pilot" doesn't appear anywhere in that source's text — the schema has no way to flag "this is an editorial addition, not a verbatim source term," and a reader has no way to know which other entries might carry similar unmarked additions. | 2 |
| Querying | If a reader-path branch-point simulation and paraphrase test were conducted, what would it reveal about the clarity of the response? | The two Lu MRI entries' near-identical DOI-prefix codes and shared author/institution create a superficial confusion risk that resolves cleanly once titles are checked. A fresh instance of the truncated-author-list ambiguity (src_zhang_2022_ratio's two-item list of bare initials) persists. Tags generally don't distinguish "primary subject of the paper" from "mentioned in passing," requiring readers to verify against the title. | 2 |

**Sum = 2+3+2+2 = 9 → PASS**

## Completeness

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a topic-coverage grid with cross-examination analysis to cite instances of missing facts/data and concepts in the response. | A topic-coverage grid found core citation fields 9/9 complete, but sample size (n) is present in 0/9 entries — a systematic, foundational gap for a knowledge base whose purpose depends on evaluating diagnostic-study quality. Gestational-timing tags are present in only 5/9 entries despite being knowable and mostly narrow for the other 4. No field anywhere flags which author (if any) is the corresponding author. Weighted coverage ≈76%. | 2 |
| Non-contextual | Discover the completeness of the response. | A concept-inventory check (not value-level, but whole-concept-level) found PAS severity/depth-subtype classification (accreta/increta/percreta, FIGO grade) entirely unrepresented in the schema, despite being reported in at least 4 of 9 sources. Case/control group-matching methodology (e.g., gestational-age matching) is similarly nowhere captured. | 2 |
| Argumentative | Argue defensively or accusatorily whether the response is complete using a topic-coverage grid and cross-examination analysis. | Defense: ethics/funding/statistical-methodology detail is reasonably delegated to the linked wiki pages, not duplicated in a citation registry. Accusation: the cohort_overlap_flag cites "overlapping dates" as justification but records no actual date-range fields anywhere, so its own claim can't be verified from within the registry; and "control" group composition varies structurally across studies (3-arm vs. 2-arm vs. matched) with no field flagging this, undermining cross-study biomarker comparisons the file itself makes elsewhere. | 2 |
| Querying | If a topic-coverage grid were created with cross-examination as a complement, what would it reveal about the completeness of the response? | A grid crossing each entry against "is the specific biomarker studied named anywhere in Response A's own text" found 5 of 9 entries name their biomarker(s) directly in the title; for the other 4 (plus one partial), a reader must leave the registry entirely (open the PDF or reverse-search the biomarker findings elsewhere in the file) to learn what the source actually measured — a real functional gap for a biomarker-focused knowledge base. | 2 |

**Sum = 2+2+2+2 = 8 → PASS**

## Falsity

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a necessary-condition falsification test followed by an adversarial steelman test to cite instances of false, materialized information in the response. | A necessary-condition sweep across titles, authors, years, journals, DOIs, and both flags found no fabrication. The one candidate — src_shang_2025's `retrospective-cohort` tag technically misdescribing what is definitionally a case-control design — survives steelman-testing as a real-world terminology looseness rather than a hallucinated design, since every underlying fact (n=120, 68/52 split, retrospective, single institution) is stated correctly elsewhere in the same entry. | 3 |
| Non-contextual | Discover the falsity of the response. | A plain-restatement test (blunt one-sentence summary per entry, checked against verified facts) found no false claim across all 9 entries. src_shang_2025's "2025" reflects a legitimate online-publication-date convention, not a fabricated year, despite the print-issue carrying a 2026 label. | 3 |
| Argumentative | Argue defensively or accusatorily whether the response has falseness using a necessary-condition falsification test and a verifying adversarial steelman test. | This pass targeted the verification process itself: only 4 of 9 entries were confirmed via direct source reading, with 5 resting on a background research agent's extraction. The accusation (an undetected subagent error could exist) is steelmanned against by independent structural cross-checks I performed myself (DOI-suffix/filename matching, source_id/year consistency) which turned up no contradictions, and by the specificity/falsifiability of the fork's reported details (exact scanner model, exact dates) — a hallucinating summary would more plausibly produce vague claims. | 3 |
| Querying | If a necessary-condition falsification test and an adversarial steelman test were conducted, what would it reveal about the falsity of the response? | Testing `local_file` and `doi` base-existence claims directly: all 9 local_file paths opened successfully and matched their entries' other claimed metadata; all 4 directly-read DOIs matched the string printed on the actual document. One explicit boundary noted: `wiki_page` file-existence was never tested, per the established scope for this validation — its clean record reflects an untested claim, not a confirmed-true one. | 3 |

**Sum = 3+3+3+3 = 12 → PASS**

## Response A — Summary

| Category | Sum | Verdict |
|---|---|---|
| Accuracy | 9 | PASS |
| Relevance | 11 | PASS |
| Clarity | 9 | PASS |
| Completeness | 8 | PASS |
| Falsity | 12 | PASS |
**Verdict:** PASS

All 5 categories pass. The consistent pattern across this response was terminology-consistency drift (dropped design qualifiers, one internal study_type/tag contradiction on src_shang_2025, an under-scoped `proteomics` tag) and structural completeness gaps (no sample-size field, no PAS-severity/subtype field, no source→biomarker index, no corresponding-author flag) — real, well-evidenced findings, but none rose to fabricated or materially false content across any of the 20 cells.

---

# Response B

**Text under evaluation**: lines 636–771 (full `free_beta_hCG` biomarker entry — header fields plus `findings` + `assay_note`; full PAPP-A entry; full PlGF entry). *Correction, 2026-08-04: this was originally scoped as 646–771, omitting the biomarker header (full_name/conditions/sample_types/technologies, lines 636–640) and one finding (lines 642–644). The omitted content was checked against src_ijms25_09722 and found accurate (the finding is a verbatim match to Table 1, ref 30/Büke et al.); no score changed as a result, except that the Clarity/Contextual cell's "orphaned finding, missing source_id" observation is retracted below, since the corrected range shows that finding's source_id header falls inside Response B after all.*

**Comparison material**: src_ijms25_09722, src_ijms26_06187, src_shang_2025, src_cai_2022, src_givens_2024, src_balkas_2023, src_zhang_2022_ratio — all 7 read directly in full.

## Accuracy

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a terminology-substitution audit to cite instances of incorrect rephrasing and misleading language in the response. | A single systematic pattern recurs across all three biomarkers: src_givens_2024's β-hCG finding pairs `odds_ratio: 4.06, ci_95: [1.72, 9.57]` with `n_studies: 6`, but the source states this exact OR/CI is from a "single study" (Hung et al.). The PAPP-A finding pairs `mean_difference: 0.52, ci_95: [0.36, 0.68]` with `n_studies: 6`; the source attributes this exact MD/CI to a "single study" (Penzhoyan). The PlGF finding pairs `mean_difference: -36.14, ci_95: [-45.18, -25.09]` with `n_studies: 7`; the source attributes this MD/CI to "two studies." In each case, `n_studies` substitutes a broader study-count for "studies underlying this specific pooled statistic." | 1 |
| Non-contextual | Discover the accuracy of the response. | A claim-by-claim ledger of every other numeric field found near-perfect exactness: src_ijms25_09722 (8/8 findings match Table 1 verbatim, including the biomarker's opening finding at lines 642–644), src_zhang_2022_ratio (AUC 0.93/0.90/0.65, sens/spec 86/93 exact), src_balkas_2023 (MoM 1.96/0.88/0.89 and "ns" exact), src_cai_2022 (AUC 0.754, sens/spec 83.33/70.00, combined AUC 0.916 exact), src_shang_2025 (AUC 0.818, cutoff 276.51 ng/mL exact; combined "0.88" vs. source's 0.881, a minor rounding). Against this overwhelmingly clean ledger, the three n_studies mismatches stand out as isolated but real. | 2 |
| Argumentative | Argue defensively or accusatorily whether the response is accurate using a terminology-substitution audit. | Defense: every single-value numeric claim checked across 7 sources and 16 findings is exact, zero fabricated numbers anywhere. Accusation: beyond the n_studies pattern, src_ijms25_09722's "(total protein)" qualifier and "technology_used: qPCR" are plausible but not actually stated in the source's Table 1; the PlGF finding citing Arakaza et al. omits that source's own caveat that PlGF predicts PAS presence but not FIGO severity grade. | 1 |
| Querying | If a terminology-substitution audit was conducted, what would it reveal about the response's accuracy? | Of 16 findings: 13 are verbatim-exact matches; 3 carry the n_studies mismatch; 2 (a subset of the 13) carry unsourced additions ("(total protein)," "qPCR"); 1 omits a source-stated caveat (PlGF/FIGO). The dominant issue is structural — appearing once per biomarker — suggesting a systematic drafting habit rather than scattered independent errors. | 1 |

**Sum = 1+2+1+1 = 5 → FAIL**

## Relevance

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a counterfactual removal test to cite instances of scope oscillation through suggestively irrelevant details in the response not found in the source. | Every field across all 16 findings is a verified numeric statistic or source-traceable note; nothing reads as padding. The assay_note, contradiction_note, and caution_note are all substantive, verified content — none removable without losing information needed to correctly interpret the surrounding numbers. | 3 |
| Non-contextual | Discover the relevance of the response. | Scope-membership classification: all 16 findings are direct measurements or pooled statistics for the three named biomarkers in PAS/previa populations — 100% on-topic. | 3 |
| Argumentative | Argue defensively or accusatorily whether the response is relevant using a counterfactual removal test. | Defense: entry-level testing shows no two findings within a biomarker are redundant — src_ijms25_09722's two PAPP-A findings make genuinely different claims; its three PlGF findings differ by sample type and severity framing. Accusation-tested candidate: src_ijms26_06187's second PAPP-A finding (control-vs-PP, "no significant difference vs. PAS") — removing it would lose the important fact that PAPP-A doesn't distinguish PAS from PP specifically, so it survives as necessary. | 3 |
| Querying | If a counterfactual removal test were conducted, what would it reveal about the relevance of the response? | `technologies: [immunoassay, qPCR]` at the biomarker level is broad enough to cover src_shang_2025's chemiluminescence method (a form of immunoassay) without needing a finding-level tag for every entry — appropriately economical. No field found removable without loss. | 3 |

**Sum = 3+3+3+3 = 12 → PASS**

## Clarity

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a reader-path branch-point simulation and paraphrase test to cite instances of un-conciseness and ambiguity in the response. | The `full_name` field — "Free/total beta subunit of human chorionic gonadotropin (both protein and cell-free mRNA forms discussed across sources)" — creates a branch point: is "Free/total" part of the assay's actual name, or shorthand for "this entry covers both the free and total forms"? A field meant to hold a formal name instead mixes in a scope note, which a reader has to parse out. Separately, `n_studies` carries two different implicit meanings across the section (see Accuracy) without any distinguishing label. | 2 |
| Non-contextual | Discover the clarity of the response. | Structural inventory: PAPP-A uses `contradiction_flag: true` + `contradiction_note`; PlGF uses `contradiction_flag: false` + `caution_note` for an arguably similar underlying phenomenon (a genuine split in pooled evidence) — no clear rule distinguishes when a split earns "contradiction" vs. "caution." | 2 |
| Argumentative | Argue defensively or accusatorily whether the response is clear using a reader-path branch-point simulation and paraphrase test. | Defense: the "(total protein)" and "qPCR" additions genuinely aid interpretation rather than obscuring anything, being plausible standard inferences. Accusation: nothing in the schema distinguishes "extracted verbatim" from "inferred by the compiler" — a reader can't tell which fields are which, echoing the same schema-level gap found in Response A. | 2 |
| Querying | If a reader-path branch-point simulation and paraphrase test were conducted, what would it reveal about the clarity of the response? | `direction: mixed` is used for both the β-hCG/givens_2024 finding (elevated-leaning: 2/1/3) and the PlGF/givens_2024 finding (higher-leaning: 3/2 per the note) — a reader has no way to know these two "mixed" labels describe differently-shaped distributions without reading each note in full. | 2 |

**Sum = 2+2+2+2 = 8 → PASS**

## Completeness

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | As a critic, use a topic-coverage grid with cross-examination analysis to cite instances of missing facts/data and concepts in the response. | Missing: the PlGF/Arakaza finding's FIGO-severity caveat; any sample-size (n) field anywhere in Response B's 16 findings; and — most significantly — no field discloses the actual number of studies underlying each pooled OR/MD statistic (1, 1, and 2 respectively), since n_studies is occupied by the broader count. A reader can't gauge how much evidentiary weight each pooled statistic carries. | 1 |
| Non-contextual | Discover the completeness of the response. | Givens et al.'s own internal inconsistency about Penzhoyan's PAPP-A direction (described as "higher levels" with the MD statistic in one place, and as "the one exception" that did *not* show higher levels in another place within the same source) is inherited silently by the wiki's note without any flag that the source itself is internally ambiguous on this point. | 1 |
| Argumentative | Argue defensively or accusatorily whether the response is complete using a topic-coverage grid and cross-examination analysis. | Defense: granular per-study methodology is reasonably left to the linked wiki biomarker pages. Accusation: the n_studies-behind-statistic gap is not a granular detail being reasonably delegated — it's the single number needed to correctly weight the pooled figures the response itself prominently displays, and its absence directly enables the accuracy problem identified above. | 1 |
| Querying | If a topic-coverage grid were created with cross-examination as a complement, what would it reveal about the completeness of the response? | Mirroring Response A's parallel finding, none of Givens et al.'s stated evidence-gap conclusions (unavailable cutoffs for most biomarkers, gestational-age variability, overlap with other placental complications) are carried into Response B's notes, despite this framing being central to how the source characterizes the evidence. | 2 |

**Sum = 1+1+1+2 = 5 → FAIL**

## Falsity

| Style          | Prompt                                                                                                                                                                   | Finding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Score |
| -------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | As a critic, use a necessary-condition falsification test followed by an adversarial steelman test to cite instances of false, materialized information in the response. | Necessary-condition test: for src_givens_2024's β-hCG finding to be accurate, n_studies:6 would need to describe the OR/CI statistic beside it — it doesn't (source says "single study"). Steelman: the accompanying note ("3 of 6 elevated...") could be read as clarifying n_studies refers to the qualitative breakdown, not the OR — partially rescuing β-hCG/PAPP-A. The steelman applies less cleanly to PlGF, whose n_studies:7 sits beside a note that itself sums to 5 (2 lower + 3 higher), not 7 — an internal gap even within the note's own accounting. The charge substantially survives for PlGF, partially survives for β-hCG/PAPP-A. | 1     |
| Non-contextual | Discover the falsity of the response.                                                                                                                                    | Plain-restatement test: "this odds ratio of 4.06 comes from 6 studies" — false per the source's own words ("single study"). "This mean difference of -36.14 comes from 7 studies" — false per the source's own words ("two studies"). Stripped of the softening note-field context, both restatements are directly contradicted by the comparison source.                                                                                                                                                                                                                                                                                             | 1     |
| Argumentative  | Argue defensively or accusatorily whether the response has falseness using a necessary-condition falsification test and a verifying adversarial steelman test.           | Process-reliability angle, inverted from Response A: all 7 of Response B's sources were read in full directly for this validation (vs. Response A's partial 4/9), meaning the n_studies findings rest on complete, first-hand confirmation rather than partial/proxied extraction — strengthening rather than weakening confidence that the mismatch is real, confirmed at the highest achievable evidentiary standard for this exercise.                                                                                                                                                                                                             | 1     |
| Querying       | If a necessary-condition falsification test and an adversarial steelman test were conducted, what would it reveal about the falsity of the response?                     | Testing whether every number traces to a real printed source value: all 18 non-n_studies statistics (AUCs, sensitivities, specificities, cutoffs, MoMs, the OR, both MDs) were located verbatim in their sources. The three n_studies values are the only fields that don't trace cleanly to what they're paired with — confirming the pattern is narrow (one field, recurring) rather than pervasive across all numeric content.                                                                                                                                                                                                                     | 1     |

**Sum = 1+1+1+1 = 4 → FAIL**

## Response B — Summary

| Category | Sum | Verdict |
|---|---|---|
| Accuracy | 5 | FAIL |
| Relevance | 12 | PASS |
| Clarity | 8 | PASS |
| Completeness | 5 | FAIL |
| Falsity | 4 | FAIL |
**Verdict:** FAIL

Response B's central, well-triangulated finding is a systematic pattern — confirmed independently in all three biomarker sub-sections — of pairing a pooled-statistic field (`odds_ratio` or `mean_difference` with its `ci_95`) with an `n_studies` value that actually describes a broader count of studies discussing that biomarker generally, not the (much smaller: 1, 1, or 2) number of studies the specific statistic was drawn from. Every other numeric claim across 16 findings and 7 fully-verified sources was exact. Unlike Response A, where the central issue was a single isolated finding, Response B's issue is structural and repeats identically across the section — arguably more systemic, though still confined to one specific field-pairing pattern rather than affecting the underlying scientific numbers themselves.

---

## Document-level summary: Response A vs. Response B

| Category     | Response A | Response B |
| ------------ | ---------- | ---------- |
| Accuracy     | 9 (PASS)   | 5 (FAIL)   |
| Relevance    | 11 (PASS)  | 12 (PASS)  |
| Clarity      | 9 (PASS)   | 8 (PASS)   |
| Completeness | 8 (PASS)   | 5 (FAIL)   |
| Falsity      | 12 (PASS)  | 4 (FAIL)   |

**Verdicts**: A: PASS; B: FAIL

Response A (the source registry) and Response B (the β-hCG/PAPP-A/PlGF findings) fail in different categories for different structural reasons. Response A's failures were narrow and disclosed-but-imprecise (dropped design qualifiers, one internal study_type/tag contradiction, missing structural fields like sample size). Response B's failures are concentrated and repeat identically three times (the n_studies/pooled-statistic mismatch), plus a completeness gap that is the direct downstream consequence of that same pattern — making Response B's issues more systemic, if narrower in surface area, than Response A's.
